NCT02105012
- Conditions
- Asthma, Bronchial Diseases, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Pearl Therapeutics Study Site Athens, Alabama, United States
- Pearl Therapeutics Study Site Birmingham, Alabama, United States
- Pearl Therapeutics Study Site Foley, Alabama, United States
- Pearl Therapeutics Study Site Los Angeles, California, United States